Literature DB >> 22875804

Enhanced Tim3 activity improves survival after influenza infection.

Josalyn L Cho1, Marly I Roche, Barry Sandall, Abraham L Brass, Brian Seed, Ramnik J Xavier, Benjamin D Medoff.   

Abstract

Influenza is a major cause of morbidity and mortality in the United States. Studies have shown that excessive T cell activity can mediate pneumonitis in the setting of influenza infection, and data from the 2009 H1N1 pandemic indicate that critical illness and respiratory failure postinfection were associated with greater infiltration of the lungs with CD8+ T cells. T cell Ig and mucin domain 3 (Tim3) is a negative regulator of Th1/Tc1-type immune responses. Activation of Tim3 on effector T cells has been shown to downregulate proliferation, cell-mediated cytotoxicity, and IFN-γ production, as well as induce apoptosis. In this article, we demonstrate that deletion of the terminal cytoplasmic domain of the Tim3 gene potentiates its ability to downregulate Tc1 inflammation, and that this enhanced Tim3 activity is associated with decreased phosphorylation of the TCR-CD3ζ-chain. We then show that mice with this Tim3 mutation infected with influenza are protected from morbidity and mortality without impairment in viral clearance or functional heterotypic immunity. This protection is associated with decreased CD8+ T cell proliferation and decreased production of inflammatory cytokines, including IFN-γ. Furthermore, the Tim3 mutation was protective against mortality in a CD8+ T cell-specific model of pneumonitis. These data suggest that Tim3 could be targeted to prevent immunopathology during influenza infection and demonstrate a potentially novel signaling mechanism used by Tim3 to downregulate the Tc1 response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875804      PMCID: PMC3436990          DOI: 10.4049/jimmunol.1102483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

Review 1.  T cell Ig and mucin domain proteins and immunity.

Authors:  Lawrence P Kane
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

2.  Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

Authors:  Rachel H McMahan; Lucy Golden-Mason; Michael I Nishimura; Brian J McMahon; Michael Kemper; Todd M Allen; David R Gretch; Hugo R Rosen
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

3.  Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.

Authors:  Sharvan Sehrawat; Pradeep B J Reddy; Naveen Rajasagi; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

4.  Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.

Authors:  Julien Fourcade; Zhaojun Sun; Mourad Benallaoua; Philippe Guillaume; Immanuel F Luescher; Cindy Sander; John M Kirkwood; Vijay Kuchroo; Hassane M Zarour
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

5.  Lung pathology in fatal novel human influenza A (H1N1) infection.

Authors:  Thais Mauad; Ludhmila A Hajjar; Giovanna D Callegari; Luiz F F da Silva; Denise Schout; Filomena R B G Galas; Venancio A F Alves; Denise M A C Malheiros; Jose O C Auler; Aurea F Ferreira; Marcela R L Borsato; Stephania M Bezerra; Paulo S Gutierrez; Elia T E G Caldini; Carlos A Pasqualucci; Marisa Dolhnikoff; Paulo H N Saldiva
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

6.  TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.

Authors:  William D Hastings; David E Anderson; Nasim Kassam; Ken Koguchi; Edward A Greenfield; Sally C Kent; Xin Xiao Zheng; Terry B Strom; David A Hafler; Vijay K Kuchroo
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

7.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

9.  Host adaptive immunity deficiency in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Ignacio Martin-Loeches; Jordi Rello; Andres Antón; Raquel Almansa; Luoling Xu; Guillermo Lopez-Campos; Tomás Pumarola; Longsi Ran; Paula Ramirez; David Banner; Derek Cheuk Ng; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Maria J Gómez-Sánchez; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Sara Aldunate; Cristobal León; Pedro Merino; Jesús Blanco; Fernando Martin-Sanchez; Lucia Rico; David Varillas; Veronica Iglesias; Maria Ángeles Marcos; Francisco Gandía; Felipe Bobillo; Begoña Nogueira; Silvia Rojo; Salvador Resino; Carmen Castro; Raul Ortiz de Lejarazu; David Kelvin
Journal:  Crit Care       Date:  2010-09-14       Impact factor: 9.097

10.  The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Authors:  Abraham L Brass; I-Chueh Huang; Yair Benita; Sinu P John; Manoj N Krishnan; Eric M Feeley; Bethany J Ryan; Jessica L Weyer; Louise van der Weyden; Erol Fikrig; David J Adams; Ramnik J Xavier; Michael Farzan; Stephen J Elledge
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

View more
  11 in total

1.  Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.

Authors:  Shaoyu Li; Yuejie Zhu; Song Wang; Yujiao Li; Nannan Pang; Mengting An; Fengbo Zhang; Jianbing Ding
Journal:  Mol Biol Rep       Date:  2022-06-17       Impact factor: 2.742

Review 2.  Regulation of T cell responses by the receptor molecule Tim-3.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.

Authors:  Guohe Lin; Yongcheng Liu; Shuhong Li; Yize Mao; Jun Wang; Zeyu Shuang; Jianlin Chen; Shengping Li
Journal:  Oncotarget       Date:  2016-08-09

Review 4.  CEACAM1 as a multi-purpose target for cancer immunotherapy.

Authors:  Matthew Dankner; Scott D Gray-Owen; Yu-Hwa Huang; Richard S Blumberg; Nicole Beauchemin
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

5.  Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4.

Authors:  Zamaneh Mikhak; James P Strassner; Andrew D Luster
Journal:  J Exp Med       Date:  2013-08-19       Impact factor: 14.307

Review 6.  Altering cell death pathways as an approach to cure HIV infection.

Authors:  A D Badley; A Sainski; F Wightman; S R Lewin
Journal:  Cell Death Dis       Date:  2013-07-11       Impact factor: 8.469

7.  TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.

Authors:  Brian Tomkowicz; Eileen Walsh; Adam Cotty; Raluca Verona; Nina Sabins; Fred Kaplan; Sandy Santulli-Marotto; Chen-Ni Chin; Jill Mooney; Russell B Lingham; Michael Naso; Timothy McCabe
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

8.  Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection.

Authors:  Marion C Lanteri; Michael S Diamond; Jacqueline P Law; Glen M Chew; Shiquan Wu; Heather C Inglis; Derek Wong; Michael P Busch; Philip J Norris; Lishomwa C Ndhlovu
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

9.  Dedifferentiation of committed epithelial cells into stem cells in vivo.

Authors:  Purushothama Rao Tata; Hongmei Mou; Ana Pardo-Saganta; Rui Zhao; Mythili Prabhu; Brandon M Law; Vladimir Vinarsky; Josalyn L Cho; Sylvie Breton; Amar Sahay; Benjamin D Medoff; Jayaraj Rajagopal
Journal:  Nature       Date:  2013-11-06       Impact factor: 49.962

10.  Near Equilibrium Calculus of Stem Cells in Application to the Airway Epithelium Lineage.

Authors:  Zheng Sun; Maksim V Plikus; Natalia L Komarova
Journal:  PLoS Comput Biol       Date:  2016-07-18       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.